Lanford RE et al. |
Comparison of tamarins and marmosets as hosts for GBV-B infections and the effect of immunosuppression on duration of viremia. |
2003 |
Virology |
pmid:12832204
|
Stremlau M et al. |
Cyclophilin A: an auxiliary but not necessary cofactor for TRIM5alpha restriction of HIV-1. |
2006 |
Virology |
pmid:16643975
|
Goldfeld AE et al. |
Cyclosporin A and FK506 block induction of the Epstein-Barr virus lytic cycle by anti-immunoglobulin. |
1995 |
Virology |
pmid:7538254
|
Zhao W et al. |
Role of cellular FKBP52 protein in intracellular trafficking of recombinant adeno-associated virus 2 vectors. |
2006 |
Virology |
pmid:16828834
|
MistrÃková J et al. |
Increased neoplasm development due to immunosuppressive treatment with FK-506 in BALB/C mice persistently infected with the mouse herpesvirus (MHV-72). |
1999 |
Viral Immunol. |
pmid:10532652
|
Gambarino S et al. |
Human Cytomegalovirus Impact on mir-146a Expression Levels in Kidney Transplant Patients. |
2016 |
Viral Immunol. |
pmid:27077822
|
Shen ZY et al. |
Variations in the S and P regions of the hepatitis B virus genome under immunosuppression in vitro and in vivo. |
2012 |
Viral Immunol. |
pmid:22946668
|
Mortola E et al. |
The use of two immunosuppressive drugs, cyclosporin A and tacrolimus, to inhibit virus replication and apoptosis in cells infected with feline immunodeficiency virus. |
1998 |
Vet. Res. Commun. |
pmid:10066129
|
Tanaka Y et al. |
Suppression of feline coronavirus replication in vitro by cyclosporin A. |
2012 |
Vet. Res. |
pmid:22546085
|
Kano R et al. |
Treatment of sterile panniculitis in a dog. |
2004 |
Vet. Rec. |
pmid:15134169
|
Ofri R et al. |
Clinical evaluation of pimecrolimus eye drops for treatment of canine keratoconjunctivitis sicca: a comparison with cyclosporine A. |
2009 |
Vet. J. |
pmid:17950639
|
Sestak K et al. |
Tacrolimus-FK506 induced immunosuppression in gnotobiotic piglets. |
2000 |
Vet. Immunol. Immunopathol. |
pmid:11137126
|
Marsella R et al. |
Investigation on the clinical efficacy and safety of 0.1% tacrolimus ointment (Protopic) in canine atopic dermatitis: a randomized, double-blinded, placebo-controlled, cross-over study. |
2004 |
Vet. Dermatol. |
pmid:15500481
|
Marsella R and Nicklin CF |
Investigation on the use of 0.3% tacrolimus lotion for canine atopic dermatitis: a pilot study. |
2002 |
Vet. Dermatol. |
pmid:12174182
|
Banovic F et al. |
Therapeutic effectiveness of calcineurin inhibitors in canine vesicular cutaneous lupus erythematosus. |
2017 |
Vet. Dermatol. |
pmid:28439997
|
Olivry T et al. |
Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from the International Task Force on Canine Atopic Dermatitis. |
2010 |
Vet. Dermatol. |
pmid:20456716
|
Marsella R et al. |
Investigation on the effects of topical therapy with 0.1% tacrolimus ointment (Protopic) on intradermal skin test reactivity in atopic dogs. |
2004 |
Vet. Dermatol. |
pmid:15305928
|
Kelley LS et al. |
Safety and tolerability of 0.1% tacrolimus solution applied to the external ear canals of atopic beagle dogs without otitis. |
2010 |
Vet. Dermatol. |
pmid:20609208
|
Bensignor E and Olivry T |
Treatment of localized lesions of canine atopic dermatitis with tacrolimus ointment: a blinded randomized controlled trial. |
2005 |
Vet. Dermatol. |
pmid:15725106
|
Scholz FM et al. |
Focal metatarsal fistulae syndrome affecting a greyhound dog successfully treated with topical 0.1% tacrolimus ointment. |
2015 |
Vet. Dermatol. |
pmid:26216245
|